They demonstrated that SET8 promotes epithelial-mesenchymal transition (EMT) and enhances the invasive capacity of breast cancer cells via functional interdependence with a transcription factor TWIST and through dual chromatin remodelling activity. Here, KMT5A is linked to breast cancer.